NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC)

Q: What does CUSIP 64130M209 represent in this 13F holders report?

CUSIP 64130M209 is the security identifier for NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share in Q2 2022?

8 institutional investors reported NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 64130M209

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value, $0.001 per share
Shares outstanding: 50,013,453
Total 13F shares: 479,839
Share change: -227,209
Total reported value: $394,000
Price per share: $0.82
Number of holders: 8
Value change: -$269,817
Number of buys: 4
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 64130M209:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
AWM Investment Company, Inc.	13F	Company	— class O/S missing	1,414,172	$1,556,000	—	31 Mar 2022	13F
Stonepine Capital Management, LLC	13F	Company	0.5%	248,105	$273,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	0.48%	239,391	$264,000	—	31 Mar 2022	13F
DRIVE WEALTH MANAGEMENT, LLC	13F	Company	0.13%	66,667	$73,000	—	31 Mar 2022	13F
Intersect Capital LLC	13F	Company	0.1%	50,000	$55,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	37,245	$40,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	34,777	$38,000	—	31 Mar 2022	13F
Virtu Financial LLC	13F	Company	0.03%	15,487	$17,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.03%	15,376	$17,000	—	31 Mar 2022	13F

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q2 2022

As of 30 Jun 2022, NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 479,839 shares. The largest 8 holders included VANGUARD GROUP INC, DRIVE WEALTH MANAGEMENT, LLC, Kingsbury Capital Investment Advisors LLC, Intersect Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Tower Research Capital LLC (TRC), and UBS Group AG. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.